{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:07:44Z","timestamp":1763017664104},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2464-1","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T08:36:59Z","timestamp":1467621419000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: a report of two cases"],"prefix":"10.1186","volume":"16","author":[{"given":"Koichi","family":"Mitsuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nakasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakamasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"2464_CR1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1209124","volume":"367","author":"S Verma","year":"2012","unstructured":"Verma S, Miles D, Gianni L, Krop IE, Welslau M, Baselga J, et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med. 2012;367:1783\u201391.","journal-title":"N Engl J Med"},{"key":"2464_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jjco\/hyu160","volume":"45","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto H, Ando M, Aogi K, Iwata H, Tamura K, Yonemori K, et al. Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer. Jpn J Clin Oncol. 2015;45:12\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"2464_CR3","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/neuonc\/not329","volume":"16","author":"JA Carlson","year":"2014","unstructured":"Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, et al. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol. 2014;16:1006\u20139.","journal-title":"Neuro Oncol"},{"key":"2464_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3171\/2014.10.JNS141610","volume":"123","author":"PK Sneed","year":"2015","unstructured":"Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg. 2015;123:373\u201386.","journal-title":"J Neurosurg"},{"key":"2464_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(99)00507-6","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90\u201305. Int J Radiat Oncol Biol Phys. 2000;47:291\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2464_CR6","first-page":"157","volume-title":"INSERM Symposium on Stereotactic Irradiations. INSERM Symposia, Vol 12","author":"RN Kjellberg","year":"1979","unstructured":"Kjellberg RN. Isoeffective dose parameters for brain necrosis in relation to proton radiosurgical dosimetry. In: Szikla G, editor. INSERM Symposium on Stereotactic Irradiations. INSERM Symposia, Vol 12. Amsterdam: Elsevier; 1979. p. 157\u201366."},{"key":"2464_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/02841869109092387","volume":"30","author":"JC Flickinger","year":"1991","unstructured":"Flickinger JC, Lunsford LD, Wu A, Kalend A. Predicted dose-volume isoeffect curves for stereotactic radiosurgery with the 60Co gamma unit. Acta Oncol. 1991;30:363\u20137.","journal-title":"Acta Oncol"},{"key":"2464_CR8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3171\/jns.1996.84.5.0874","volume":"84","author":"H Kurita","year":"1996","unstructured":"Kurita H, Sasaki T, Kawamoto S, Taniguchi M, Kitanaka C, Nakaguchi H, et al. Chronic encapsulated expanding hematoma in association with gamma knife stereotactic radiosurgery for a cerebral arteriovenous malformation. Case report. J Neurosurg. 1996;84:874\u20138.","journal-title":"J Neurosurg"},{"issue":"Suppl","key":"2464_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3171\/2012.6.GKS12318","volume":"117","author":"T Shuto","year":"2012","unstructured":"Shuto T, Ohtake M, Matsunaga S. Proposed mechanism for cyst formation and enlargement following Gamma Knife Surgery for arteriovenous malformations. J Neurosurg. 2012;117(Suppl):135\u201343.","journal-title":"J Neurosurg"},{"key":"2464_CR10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10549-014-3001-z","volume":"146","author":"V Sibaud","year":"2014","unstructured":"Sibaud V, Niec RE, Schindler K, Busam KJ, Roch\u00e9 H, Modi S, et al. Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series. Breast Cancer Res Treat. 2014;146:451\u20136.","journal-title":"Breast Cancer Res Treat"},{"key":"2464_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-205680","author":"S Torres","year":"2014","unstructured":"Torres S, Maralani P, Verma S. Activity of T-DM1 in HER-2 positive central nervous system breast cancer metastases. BMJ Case Rep. 2014. doi: 10.1136\/bcr-2014-205680 .","journal-title":"BMJ Case Rep"},{"key":"2464_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-013-1257-5","volume":"116","author":"R Bartsch","year":"2014","unstructured":"Bartsch R, Berghoff AS, Preusser M. Breast cancer brain metastases responding to primary systemic therapy with T-DM1. J Neurooncol. 2014;116:205\u20136.","journal-title":"J Neurooncol"},{"key":"2464_CR13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10585-015-9740-3","volume":"32","author":"R Bartsch","year":"2015","unstructured":"Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, et al. Activity of T-DM1 in Her2-positive breast cancer brain metastases. Clin Exp Metastasis. 2015;32:729\u201337.","journal-title":"Clin Exp Metastasis"},{"key":"2464_CR14","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/j.clbc.2014.10.003","volume":"15","author":"R Kalsi","year":"2015","unstructured":"Kalsi R, Feigenberg S, Kwok Y, Tkaczuk K, Mehta M, Chumsri S. Brain metastasis and response to ado-trastuzumab emtansine: a case report and literature review. Clin Breast Cancer. 2015;15:e163\u20136.","journal-title":"Clin Breast Cancer"},{"key":"2464_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00701-014-2298-z","volume":"157","author":"T Shuto","year":"2015","unstructured":"Shuto T, Yagishita S, Matsunaga S. Pathological characteristics of cyst formation following gamma knife surgery for arteriovenous malformation. Acta Neurochir (Wien). 2015;157:293\u20138.","journal-title":"Acta Neurochir (Wien)"},{"key":"2464_CR16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/annonc\/mdu533","volume":"26","author":"V Sibaud","year":"2015","unstructured":"Sibaud V, Vigarios E, Combemale P, Lamant L, Lacouture ME, Lacaze JL, et al. T-DM1-related telangiectasias: a potential role in secondary bleeding events. Ann Oncol. 2015;26:436\u20137.","journal-title":"Ann Oncol"},{"key":"2464_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00795-015-0123-2","volume":"48","author":"M Furuse","year":"2015","unstructured":"Furuse M, Nonoguchi N, Kawabata S, Miyatake SI, Kuroiwa T. Delayed brain radiation necrosis: pathological review and new molecular targets for treatment. Med Mol Morphol. 2015;48:183\u201390.","journal-title":"Med Mol Morphol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2464-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T13:17:54Z","timestamp":1568121474000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2464-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2464-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]},"article-number":"391"}}